WAYNE, Pa.--(BUSINESS WIRE)--Jun. 16, 2014--
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care, urology and surgery, will present its
ARROW® brand portfolio including PICCs and CVCs
with Chlorag+ard® Technology, which provides
antimicrobial and antithrombogenic protection, ARROW® VPS™ tip location
system and the new EZ-IO® Needle + Stabilizer
Kit at the World Congress on Vascular Access in Berlin, Germany on June
18-20, 2014.
At the WoCoVA on June 18-20, Teleflex will present innovative ARROW®
brand products that are inspired by the goal of zero complications in
vascular care. This includes protection against infection, thrombosis,
occlusion and malposition.
At the booth, the Company will focus special attention on its Chlorag+ard
technology. This includes ARROW® JACC with Chlorag+ard® technology, the
world’s only antimicrobial and antithrombogenic CVC and ARROW PICC with
Chlorag+ard Technology, the world’s only antimicrobial and
antithrombogenic PICC. Additionally, the Company will highlight the new
EZ-IO® needle and stabilizer kit as well as many educational innovations.
Three Symposia are scheduled, the first of which is to be held on
Wednesday, June 18, 13:00h – 14:00h, under the title “Starting a
Vascular Access Team. Why it makes sense and how to get started”. The
Speakers will be Prof. Dr. Bernhard Gebauer, MD, PhD; Germany; Steve
Hill, APRN; UK; Jim Lacy, BSN, RN, CRNI, VA-BC; U.S.A. - this symposium
can be joined in WoCoVA room B05-06.
This will be followed by the second Symposium on Thursday, June 19, at
07:30h – 08:30h, in WoCoVA room B05-06, under the title “Antimicrobial
Catheter Technologies – Fact or Fiction – A review of Safety,
Cost-effectiveness and Efficiencies”. The speakers are: Dr. Giancarlo
Scoppettuolo, MD, PhD, Italy; Kamna Giare-Patel; U.S.A.; Dr. Philippe
Burtin, MD, PhD, France and Dr. Tanjew Stember, MD, PhD, Germany.
The third will take place on Thursday, June 19, 18:00 – 19:00, WoCoVA
room B08-09, the title being “Global Clinical Updates on the
Intraosseous route of Vascular Access”, with Chris Davlantes, MD, FACEP;
U.S.A., speaking.
During the general sessions, the Company will provide additional
information on catheter technologies, such as on the effectiveness of
eluting technology or non-eluting technology in preventing thrombus
accumulation and on the current role of central coated/treated catheters
with antibacterial/antiseptic drugs.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care, urology and surgery. Our mission
is to provide solutions that enable healthcare providers to improve
outcomes and enhance patient and provider safety. Headquartered in
Wayne, PA, Teleflex employs approximately 11,400 people worldwide and
serves healthcare providers in more than 150 countries. Additional
information about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, ARROW, VPS, EZ-IO, and Chlorag+ard are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates. ©2014
Teleflex Incorporated. All rights reserved.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com
www.teleflex.com